In clinical trials, patients on the highest dose witnessed average weight reductions of nearly 21%
Metabolism Support: The lipotropic compounds in our injections help enhance your body's ability to metabolize fat
Habit pairing Linking injections to an existing weekly habit such as a specific evening routine can reinforce consistency
Colca comes from the words Collaguas and Cabanas, two ethnic groups that lived along the Colca River
~15% average weight loss Common side effects: nausea, constipation, diarrhea Also shown to reduce cardiovascular and kidney disease risks in some patients Tirzepatide (Zepbound) A dual-action medication: GLP-1 + GIP Enhances insulin, appetite control, and fat metabolism Average weight loss: ~20% in clinical trials Weekly injection Similar GI side effects to semaglutide Retatrutide (Coming Soon) A triple-agonist: GLP-1 + GIP + glucagon receptor Early studies show weight loss approaching 25% Still in clinical trials
GLP-1 use is therefore expected to remain concentrated around these core medical and health related drivers. Also noting the initial intention behind GLP-1 medications, Keychains Madoff notes that more is being done to understand additional benefits
